Enhancer of zeste homolog 2 inhibitors | Patent Number 09562041

US 09562041 B2
Application Number14400896
Publication NumberUS 20150126522 A1
Pendency3 years, 8 months, 29 days
Filled DateMay 15, 2013
Priority DateMay 16, 2012
Publication DateMay 7, 2015
Expiration DateMay 15, 2032
Inventor/ApplicantsJoelle Lorraine Burgess
Steven David Knight
ExaminesMORRIS, PATRICIA L
Art Unit1625
Technology Center1600
Assignments
Glaxosmithkline
Current
GlaxosmithklineGlaxo Group Limited
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.